348 related articles for article (PubMed ID: 35222418)
41. Activation of the zymogen to urokinase-type plasminogen activator is associated with increased interdomain flexibility.
Behrens MA; Botkjaer KA; Goswami S; Oliveira CL; Jensen JK; Schar CR; Declerck PJ; Peterson CB; Andreasen PA; Pedersen JS
J Mol Biol; 2011 Aug; 411(2):417-29. PubMed ID: 21669207
[TBL] [Abstract][Full Text] [Related]
42. [Roles of serine proteases and matrix metalloproteinases in tumor invasion and angiogenesis].
Masson V
Bull Mem Acad R Med Belg; 2006; 161(5):320-6. PubMed ID: 17283905
[TBL] [Abstract][Full Text] [Related]
43. Human kallikrein 13 involvement in extracellular matrix degradation.
Kapadia C; Ghosh MC; Grass L; Diamandis EP
Biochem Biophys Res Commun; 2004 Oct; 323(3):1084-90. PubMed ID: 15381110
[TBL] [Abstract][Full Text] [Related]
44. Stromal contributions to the carcinogenic process.
Spaw M; Anant S; Thomas SM
Mol Carcinog; 2017 Apr; 56(4):1199-1213. PubMed ID: 27787930
[TBL] [Abstract][Full Text] [Related]
45. [Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].
Kobayashi H
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):623-32. PubMed ID: 8808830
[TBL] [Abstract][Full Text] [Related]
46. Pro-urokinase-type plasminogen activator is a substrate for hepsin.
Moran P; Li W; Fan B; Vij R; Eigenbrot C; Kirchhofer D
J Biol Chem; 2006 Oct; 281(41):30439-46. PubMed ID: 16908524
[TBL] [Abstract][Full Text] [Related]
47. Unraveling the role of proteases in cancer.
Koblinski JE; Ahram M; Sloane BF
Clin Chim Acta; 2000 Feb; 291(2):113-35. PubMed ID: 10675719
[TBL] [Abstract][Full Text] [Related]
48. Fibroblast activation protein: A potential therapeutic target in cancer.
Liu R; Li H; Liu L; Yu J; Ren X
Cancer Biol Ther; 2012 Feb; 13(3):123-9. PubMed ID: 22236832
[TBL] [Abstract][Full Text] [Related]
49. Transforming growth factor-β, matrix metalloproteinases, and urokinase-type plasminogen activator interaction in the cancer epithelial to mesenchymal transition.
Santibanez JF; Obradović H; Kukolj T; Krstić J
Dev Dyn; 2018 Mar; 247(3):382-395. PubMed ID: 28722327
[TBL] [Abstract][Full Text] [Related]
50. Urokinase plasminogen activator secreted by cancer-associated fibroblasts induces tumor progression via PI3K/AKT and ERK signaling in esophageal squamous cell carcinoma.
Tian B; Chen X; Zhang H; Li X; Wang J; Han W; Zhang LY; Fu L; Li Y; Nie C; Zhao Y; Tan X; Wang H; Guan XY; Hong A
Oncotarget; 2017 Jun; 8(26):42300-42313. PubMed ID: 28404945
[TBL] [Abstract][Full Text] [Related]
51. Membrane-anchored serine proteases as regulators of epithelial function.
Szabo R; Bugge TH
Biochem Soc Trans; 2020 Apr; 48(2):517-528. PubMed ID: 32196551
[TBL] [Abstract][Full Text] [Related]
52. FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells.
Lee HO; Mullins SR; Franco-Barraza J; Valianou M; Cukierman E; Cheng JD
BMC Cancer; 2011 Jun; 11():245. PubMed ID: 21668992
[TBL] [Abstract][Full Text] [Related]
53. u-PAR expression in cancer associated fibroblast: new acquisitions in multiple myeloma progression.
Ciavarella S; Laurenzana A; De Summa S; Pilato B; Chillà A; Lacalamita R; Minoia C; Margheri F; Iacobazzi A; Rana A; Merchionne F; Fibbi G; Del Rosso M; Guarini A; Tommasi S; Serratì S
BMC Cancer; 2017 Mar; 17(1):215. PubMed ID: 28340565
[TBL] [Abstract][Full Text] [Related]
54. Insidious changes in stromal matrix fuel cancer progression.
Miles FL; Sikes RA
Mol Cancer Res; 2014 Mar; 12(3):297-312. PubMed ID: 24452359
[TBL] [Abstract][Full Text] [Related]
55. Catalytic properties of serine proteases. 2. Comparison between human urinary kallikrein and human urokinase, bovine beta-trypsin, bovine thrombin, and bovine alpha-chymotrypsin.
Ascenzi P; Menegatti E; Guarneri M; Bortolotti F; Antonini E
Biochemistry; 1982 May; 21(10):2483-90. PubMed ID: 7046788
[TBL] [Abstract][Full Text] [Related]
56. Platelet-derived growth factor-C (PDGF-C) activation by serine proteases: implications for breast cancer progression.
Hurst NJ; Najy AJ; Ustach CV; Movilla L; Kim HR
Biochem J; 2012 Feb; 441(3):909-18. PubMed ID: 22035541
[TBL] [Abstract][Full Text] [Related]
57. Matrix remodeling stimulates stromal autophagy, "fueling" cancer cell mitochondrial metabolism and metastasis.
Castello-Cros R; Bonuccelli G; Molchansky A; Capozza F; Witkiewicz AK; Birbe RC; Howell A; Pestell RG; Whitaker-Menezes D; Sotgia F; Lisanti MP
Cell Cycle; 2011 Jun; 10(12):2021-34. PubMed ID: 21646868
[TBL] [Abstract][Full Text] [Related]
58. Multifunctional potential of the plasminogen activation system in tumor invasion and metastasis (review).
Reuning U; Magdolen V; Wilhelm O; Fischer K; Lutz V; Graeff H; Schmitt M
Int J Oncol; 1998 Nov; 13(5):893-906. PubMed ID: 9772277
[TBL] [Abstract][Full Text] [Related]
59. Cancer. Proteases--invasion and more.
Edwards DR; Murphy G
Nature; 1998 Aug; 394(6693):527-8. PubMed ID: 9707109
[No Abstract] [Full Text] [Related]
60. Inhibition of the tumor-associated urokinase-type plasminogen activation system: effects of high-level synthesis of soluble urokinase receptor in ovarian and breast cancer cells in vitro and in vivo.
Magdolen V; Krüger A; Sato S; Nagel J; Sperl S; Reuning U; Rettenberger P; Magdolen U; Schmitt M
Recent Results Cancer Res; 2003; 162():43-63. PubMed ID: 12790320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
